Subcutaneous continuous apomorphine infusion: treatment initiation and follow up
Grandas, F.J.; Sesar-Ignacio, Án.
Revista de Neurologia 55(Suppl 1): S21-S24
2012
ISSN/ISBN: 1576-6578 PMID: 23169229 Document Number: 662003
Continuous apomorphine infusion has been an established treatment for advanced Parkinson's disease for over two decades. This article reviews the different methods for starting treatment and propose a consensus methodology for it, as well as for the modification of prior treatment, in order to standardize and reduce the variability of clinical practice.
Document emailed within 1 workday
Related Documents
Albani, C.; Zangger, I.; Fischer, G. 1992: Subcutaneous apomorphine infusion in the treatment of Parkinson disease Schweizerische Rundschau für Medizin Praxis 81(35): 1011-1015Giménez de Béjar, V.ón.; Carballo-Cordero, M. 2012: Treatment of apomorphine infusion adverse effects: subcutaneous nodules and neuropsychiatric complications Revista de Neurologia 55(Suppl 1): S25-S29
Saha, M.T.; Huupponen, T.; Komulainen, J. 1998: Continuous subcutaneous insulin infusion as a treatment of diabetes in children and adolescents Duodecim; Laaketieteellinen Aikakauskirja 114(14): 1410-1415
Costa Gil, J.E.; Galloway, J.A.; Wentworth, S.M. 1982: Treatment of diabetics with the Auto-syringe pump for the continuous infusion of insulin by the subcutaneous route Revista Clinica Espanola 164(6): 377-381
Pickup, J.C. 1984: Continuous subcutaneous insulin infusion as a treatment option: a perspective after seven years of research applications Diabetic medicine: a journal of the British Diabetic Association 1(1): 27-32
Dominguez Álvarez, R.ío.; Calderón Carrasco, J.; García Colchero, F.; Postigo Mota, S.; Alburquerque Medina, E. 2015: Pharmacological Treatment in Palliative Care. Drug Administration Route, Continuous Subcutaneous Infusion, Adverse Side Effects, Symptom Management Revista de Enfermeria 38(1): 54-58; 61-65
Bouhanick, B.; Biquard, F.; Hadjadj, S.; Roques, M.A. 2000: Does treatment with antenatal glucocorticoids for the risk of premature delivery contribute to ketoacidosis in pregnant women with diabetes who receive continuous subcutaneous insulin infusion (CSII)? Archives of Internal Medicine 160(2): 242-243
Ito, H.; Kanatsuka, A. 1997: Continuous subcutaneous insulin infusion Nihon Rinsho. Japanese Journal of Clinical Medicine 55 Suppl: 267-272
Iwaoka, H.; Makino, H.; Yoshida, S. 1989: Continuous subcutaneous insulin infusion Nihon Rinsho. Japanese Journal of Clinical Medicine 47(11): 2577-2582
Van Ballegooie, E.; Reitsma, W.D.; Sluiter, W.J.; Doorenbos, H. 1984: Feasibility and efficacy of long-term treatment by continuous subcutaneous insulin infusion (CSII) in insulin-dependent diabetes Netherlands Journal of Medicine 27(5): 185-192
Kanazawa, H.; Takahashi, K.; Hanazawa, Y.; Uchiyama, S.; Takahara, T.; Takahara, M.; Muto, M.; Kinehara, M.; Sato, K. 1989: Continuous subcutaneous infusion of peplomycin in oral squamous carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(4 Part 1): 775-780
Bremont, F.; Pienkowski, C.; Moisan, V.; Dutau, G. 1990: Continuous subcutaneous infusion of beta 2-agonists in infantile asthma Annales de Pediatrie 37(6): 360-364
Leblanc, H.; Obadia, G.; Passa, P. 1986: Reduction of hypoglycemia in 10 diabetic patients treated with continuous subcutaneous infusion of insulin Presse Medicale 15(10): 463-466
Merello, M.; Leiguarda, R. 1995: Treatment of motor fluctuations in Parkinson's disease with subcutaneous injections of apomorphine Medicina 55(1): 5-10
Liliemark, J.O.; Gahrton, G.; Paul, C.Y.; Peterson, C.O. 1987: Ara-C in plasma and ara-CTP in leukemic cells after subcutaneous injection and continuous intravenous infusion of ara-C in patients with acute nonlymphoblastic leukemia Seminars in Oncology 14(2 Suppl 1: 167-171
Li, M.; Zhou, J.; Bao, Y.-q.; Lu, W.; Jia, W.-p. 2010: Prediction of nocturnal hypoglycaemia with bedtime glucose level during continuous subcutaneous insulin infusion in type 2 diabetics Zhonghua Yi Xue Za Zhi 90(42): 2962-2966
1983: Leads from the MMWR. Toxic-shock syndrome in a patient using a continuous subcutaneous insulin infusion pump--Idaho JAMA 250(9): 1134-1135
Thomakos, P.; Panagopoulos, G.; Kepaptsoglou, O.; Zoupas, C.; Mitrakou, A. 2018: Which Factors May Affect the Quality of Life in Patients with Type 1 Diabetes Mellitus Using the Medtronic Veo Continuous Subcutaneous Insulin Infusion Pump? Georgian Medical News 2018(277): 61-67
Iorio, A.; Federici, M.Orsini.; Mourvaki, E.; Ferolla, P.; Piroddi, M.; Stabile, A.; Timi, A.; Celleno, R.; Benedetti, M.Massi. 2007: Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients Thrombosis and Haemostasis 98(3): 635-641
Walsh, T.J.; Lee, J.W.; Bacher, J.; Kelly, P.; Pizzo, P.A. 1992: Continuous intravenous infusion and simultaneous pharmacokinetic monitoring in ambulatory rabbits with a programmable micropump and dual subcutaneous Silastic central venous catheters Laboratory Animal Science 42(3): 286-292